Overview

Randomized Double Cord Blood Transplant Study

Status:
Completed

Trial end date:
2016-07-01

Target enrollment:

Participant gender:

Summary

The goal of this clinical research study is to learn if combining cord blood units to make the cells "take" faster in recipients will help to improve the results of cord blood transplants.

Phase:

Phase 2

Details

Lead Sponsor:

M.D. Anderson Cancer Center

Collaborators:

Cellgenix
National Cancer Institute (NCI)

Treatments:

Cyclophosphamide
Fludarabine
Fludarabine phosphate
Melphalan
Mesna
Rituximab
Thiotepa
Vidarabine